Head to Head Survey: Evaxion A/S (NASDAQ:EVAX) versus Mobile-health Network Solutions (NASDAQ:MNDR)

Evaxion A/S (NASDAQ:EVAX) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Volatility & Risk

Evaxion A/S has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, Mobile-health Network Solutions has a beta of -1.3, meaning that its stock price is 230% less volatile than the S&P 500.

Profitability

This table compares Evaxion A/S and Mobile-health Network Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Evaxion A/S	N/A	-73.56%	-37.45%
Mobile-health Network Solutions	N/A	N/A	N/A

Valuation and Earnings

This table compares Evaxion A/S and Mobile-health Network Solutions”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evaxion A/S	$7.53 million	4.41	-$7.71 million	($1.47)	-2.71
Mobile-health Network Solutions	$7.65 million	0.57	-$3.38 million	N/A	N/A

Mobile-health Network Solutions has higher revenue and earnings than Evaxion A/S.

Analyst Recommendations

This is a summary of current ratings and price targets for Evaxion A/S and Mobile-health Network Solutions, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evaxion A/S	1	0	5	0	2.67
Mobile-health Network Solutions	1	0	0	0	1.00

Evaxion A/S presently has a consensus price target of $11.00, indicating a potential upside of 176.04%. Given Evaxion A/S’s stronger consensus rating and higher probable upside, research analysts clearly believe Evaxion A/S is more favorable than Mobile-health Network Solutions.

Insider and Institutional Ownership

11.0% of Evaxion A/S shares are owned by institutional investors. 41.6% of Evaxion A/S shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Evaxion A/S beats Mobile-health Network Solutions on 7 of the 11 factors compared between the two stocks.

About Evaxion A/S

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based vaccine that is in Phase 1/2a trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers. Its programs also include some vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, viral vaccine product candidate for targeting Cytomegalovirus. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

About Mobile-health Network Solutions

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.